160 related articles for article (PubMed ID: 12584619)
1. [Prevalence and type of incidental extramammary findings in MRI of the breast].
Morakkabati-Spitz N; Sondermann E; Schmiedel A; Leutner C; Riehm K; Schmutzler R; Schild H; Kuhl CK
Rofo; 2003 Feb; 175(2):199-202. PubMed ID: 12584619
[TBL] [Abstract][Full Text] [Related]
2. Extramammary findings on breast MRI: prevalence and imaging characteristics favoring malignancy detection: a retrospective analysis.
Yang SM; Kim SH; Kang BJ; Song BJ
World J Surg Oncol; 2016 Apr; 14():119. PubMed ID: 27098094
[TBL] [Abstract][Full Text] [Related]
3. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
[TBL] [Abstract][Full Text] [Related]
6. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
7. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of incidental PET/CT findings suspicious for breast cancer in women with non-breast malignancies.
Beatty JS; Williams HT; Gucwa AL; Hughes MP; Vasudeva VS; Aldridge BA; Fields DM; David GS; Lind DS; Kruse EJ; McLoughlin JM
Am J Surg; 2009 Oct; 198(4):495-9. PubMed ID: 19800454
[TBL] [Abstract][Full Text] [Related]
9. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
10. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
Linda A; Zuiani C; Londero V; Bazzocchi M
Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility of MRI imaging in patients with breast cancer].
Mooyaart EA; Veltman J; Boetes C; Blickman JG
Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1521-7. PubMed ID: 16032998
[TBL] [Abstract][Full Text] [Related]
12. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
[TBL] [Abstract][Full Text] [Related]
13. MRI screening in a clinic population with a family history of breast cancer.
Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
[TBL] [Abstract][Full Text] [Related]
14. [The clinical aspects of multiple primary tumors in patients with breast cancer].
Bekhtereva SA
Vestn Khir Im I I Grek; 1996; 155(4):18-21. PubMed ID: 8992709
[TBL] [Abstract][Full Text] [Related]
15. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer.
Mameri CS; Kemp C; Goldman SM; Sobral LA; Ajzen S
Breast J; 2008; 14(3):236-44. PubMed ID: 18476882
[TBL] [Abstract][Full Text] [Related]
16. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer.
Bagley FH
Arch Surg; 2004 Apr; 139(4):380-3; discussion 383. PubMed ID: 15078704
[TBL] [Abstract][Full Text] [Related]
17. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
[TBL] [Abstract][Full Text] [Related]
18. MRI in the detection and management of breast cancer.
Padhani AR; Ah-See ML; Makris A
Expert Rev Anticancer Ther; 2005 Apr; 5(2):239-52. PubMed ID: 15877522
[TBL] [Abstract][Full Text] [Related]
19. Who should have breast magnetic resonance imaging evaluation?
Orel S
J Clin Oncol; 2008 Feb; 26(5):703-11. PubMed ID: 18258977
[TBL] [Abstract][Full Text] [Related]
20. The role of breast MRI in clinical practice.
Brennan M; Spillane A; Houssami N
Aust Fam Physician; 2009 Jul; 38(7):513-9. PubMed ID: 19575070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
